4//SEC Filing
WEISS MICHAEL S 4
Accession 0001104659-23-079112
CIK 0001680048other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:06 PM ET
Size
5.6 KB
Accession
0001104659-23-079112
Insider Transaction Report
Form 4
WEISS MICHAEL S
Exec. Chairman of the Board
Transactions
- Award
COMMON STOCK, PAR VALUE $0.0001
2023-07-05+7,246→ 49,637 total(indirect: See Footnote)
Footnotes (4)
- [F1]The Reporting Person was granted 7,246 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 5, 2023. The shares will vest on July 5, 2026, subject to the Reporting Person's continued service on the Issuer's board on such date.
- [F2]Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
- [F3]Includes restricted share units, which vest over various time periods.
- [F4]The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member.
Documents
Issuer
MUSTANG BIO, INC.
CIK 0001680048
Entity typeother
Related Parties
1- filerCIK 0001038977
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 4:06 PM ET
- Size
- 5.6 KB